Trials / Completed
CompletedNCT01673191
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Retinal Consultants of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.
Detailed description
The objective of this study is to assess the safety and efficacy of the OZURDEX® intraocular implant in patients with diabetes mellitus, who develop macular edema after cataract surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone intravitreal implant | |
| DRUG | Steroid plus NSAID eye drop combination therapy |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-08-27
- Last updated
- 2017-04-05
- Results posted
- 2017-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01673191. Inclusion in this directory is not an endorsement.